232 related articles for article (PubMed ID: 18977277)
21. [Leptin level and the PPARgamma2 Pro12Ala and Pro115Gln polymorphisms in women with functional hyperandrogenism. Preliminary report].
Bidzińska-Speichert B; Demissie M; Tworowska U; Slezak R; Dobosz T; Bednarek-Tupikowska G; Milewicz A
Przegl Lek; 2005; 62(9):833-7. PubMed ID: 16541712
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular risk in type 2 diabetes is associated with variation at the PPARG locus: a Go-DARTS study.
Doney AS; Fischer B; Leese G; Morris AD; Palmer CN
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2403-7. PubMed ID: 15486307
[TBL] [Abstract][Full Text] [Related]
23. Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosis.
Benesová Y; Vasků A; Stourac P; Hladíková M; Beránek M; Kadanka Z; Novotná H; Bednarík J
J Neuroimmunol; 2008 Dec; 205(1-2):105-9. PubMed ID: 18835646
[TBL] [Abstract][Full Text] [Related]
24. Association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma2 gene with small dense low-density lipoprotein in the general population.
Hamada T; Kotani K; Tsuzaki K; Sano Y; Murata T; Tabata M; Sato S; Sakane N
Metabolism; 2007 Oct; 56(10):1345-9. PubMed ID: 17884443
[TBL] [Abstract][Full Text] [Related]
25. Alanine variant of the Pro12Ala polymorphism of the PPARgamma gene might be associated with decreased risk of diabetic retinopathy in type 2 diabetes.
Malecki MT; Cyganek K; Mirkiewicz-Sieradzka B; Wolkow PP; Wanic K; Skupien J; Solnica B; Sieradzki J
Diabetes Res Clin Pract; 2008 Apr; 80(1):139-45. PubMed ID: 18077048
[TBL] [Abstract][Full Text] [Related]
26. T-1237C polymorphism of TLR9 gene is not associated with multiple sclerosis in the Portuguese population.
Carvalho A; Santos M; Maciel P; Rodrigues F
Mult Scler; 2008 May; 14(4):550-2. PubMed ID: 18208876
[TBL] [Abstract][Full Text] [Related]
27. P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis.
Scalabrini D; Galimberti D; Fenoglio C; Comi C; De Riz M; Venturelli E; Castelli L; Piccio L; Ronzoni M; Lovati C; Mariani C; Monaco F; Bresolin N; Scarpini E
Neurosci Lett; 2005 Nov; 388(3):149-52. PubMed ID: 16039046
[TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism, cod liver oil and risk of type 1 diabetes.
Stene LC; Thorsby PM; Berg JP; Rønningen KS; Joner G;
Pediatr Diabetes; 2008 Feb; 9(1):40-5. PubMed ID: 18211635
[TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator-activated [corrected] receptor-gamma2 [corrected] Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes.
Vogel U; Christensen J; Nexø BA; Wallin H; Friis S; Tjønneland A
Carcinogenesis; 2007 Feb; 28(2):427-34. PubMed ID: 16959787
[TBL] [Abstract][Full Text] [Related]
30. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA
Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738
[TBL] [Abstract][Full Text] [Related]
31. The role of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma in diabetes risk.
Tönjes A; Stumvoll M
Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):410-4. PubMed ID: 17563457
[TBL] [Abstract][Full Text] [Related]
32. A possible role for the PPARG Pro12Ala polymorphism in preterm birth.
Meirhaeghe A; Boreham CA; Murray LJ; Richard F; Davey Smith G; Young IS; Amouyel P
Diabetes; 2007 Feb; 56(2):494-8. PubMed ID: 17259396
[TBL] [Abstract][Full Text] [Related]
33. Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis.
Galimberti D; Scalabrini D; Fenoglio C; De Riz M; Comi C; Venturelli E; Cortini F; Piola M; Leone M; Dianzani U; D'Alfonso S; Monaco F; Bresolin N; Scarpini E
J Neurol Sci; 2008 Apr; 267(1-2):86-90. PubMed ID: 17967467
[TBL] [Abstract][Full Text] [Related]
34. The role of VLA4 polymorphisms in multiple sclerosis: an association study.
Andreoli V; Cittadella R; Valentino P; Condino F; La Russa A; Liguori M; Manna I; Spadafora P; Nisticò R; Pirritano D; Clodomiro A; Quattrone A
J Neuroimmunol; 2007 Sep; 189(1-2):125-8. PubMed ID: 17609118
[TBL] [Abstract][Full Text] [Related]
35. The peroxisome proliferator-activated receptor gamma (PPAR-gamma2) Pro12Ala polymorphism is associated with higher risk for Alzheimer's disease in octogenarians.
Scacchi R; Pinto A; Gambina G; Rosano A; Corbo RM
Brain Res; 2007 Mar; 1139():1-5. PubMed ID: 17270153
[TBL] [Abstract][Full Text] [Related]
36. FcRL3 and multiple sclerosis pathogenesis: role in autoimmunity?
Martínez A; Mas A; de Las Heras V; Bartolomé M; Arroyo R; Fernández-Arquero M; de la Concha EG; Urcelay E
J Neuroimmunol; 2007 Sep; 189(1-2):132-6. PubMed ID: 17617473
[TBL] [Abstract][Full Text] [Related]
37. No association of leukemia inhibitory factor (LIF) DNA polymorphisms with multiple sclerosis.
Vanderlocht J; Burzykowski T; Somers V; Stinissen P; Hellings N
J Neuroimmunol; 2006 Feb; 171(1-2):189-92. PubMed ID: 16263181
[TBL] [Abstract][Full Text] [Related]
38. The interleukin 23 receptor gene in multiple sclerosis: a case-control study.
Roos IM; Kockum I; Hillert J
J Neuroimmunol; 2008 Feb; 194(1-2):173-80. PubMed ID: 18164077
[TBL] [Abstract][Full Text] [Related]
39. Gender differences in the effects of peroxisome proliferator-activated receptor γ2 gene polymorphisms on metabolic adversity in patients with schizophrenia or schizoaffective disorder.
Chen CH; Lu ML; Kuo PH; Chen PY; Chiu CC; Kao CF; Huang MC
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):239-45. PubMed ID: 21095215
[TBL] [Abstract][Full Text] [Related]
40. Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with Pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals.
Tönjes A; Scholz M; Loeffler M; Stumvoll M
Diabetes Care; 2006 Nov; 29(11):2489-97. PubMed ID: 17065690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
